We’re Collecting Info on Benlysta® When Taken in Pregnancy
MotherToBaby is currently enrolling participants into an observational study examining the use of Benlysta® (belimumab) for systemic lupus erythematosus (or SLE, a type of lupus) or active lupus nephritis (lupus-related kidney inflammation) when taken during pregnancy. Our research is by observation only—we will not ask you to take or change any medications. If you join our Benlysta® study, our team will simply collect some information about your pregnancy and your baby’s development for a period of time after birth.
“Help us improve the ability for pregnant people and their healthcare providers to make safe treatment decisions by joining our Benlysta® & Pregnancy study.”
— Christina Chambers, PhD, MPH, Lead Investigator, MotherToBaby Pregnancy Studies
Our Benlysta® study includes:
- 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
- Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.
- An opportunity to receive a specialized, non-invasive exam of your baby with a study doctor
If you have lupus and have taken Benlysta® at any point in your current pregnancy or 3 months prior to pregnancy, you may qualify for this important study.
Will you take the next step and help us learn more about the use of Benlysta® during pregnancy?
